Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Nov 3, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-11-01$60.83/sh−2,500$152,075→ 99,884 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.